MX360181B - Diagnosis method for the early detection of cervicouterine cancer by detecting the eag1 protein as a marker of cervical intraepithelial lesions. - Google Patents
Diagnosis method for the early detection of cervicouterine cancer by detecting the eag1 protein as a marker of cervical intraepithelial lesions.Info
- Publication number
- MX360181B MX360181B MX2010005476A MX2010005476A MX360181B MX 360181 B MX360181 B MX 360181B MX 2010005476 A MX2010005476 A MX 2010005476A MX 2010005476 A MX2010005476 A MX 2010005476A MX 360181 B MX360181 B MX 360181B
- Authority
- MX
- Mexico
- Prior art keywords
- eag1
- protein
- detecting
- detection
- cancer
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention describes a method for the early detection of cervicouterine cancer (CuCa) by detecting the human protein Eag1 with specific antibodies. The Eag1 protein is differentially expressed in cervical tissue and in close association with the stage development of the disease, thereby cancer being detected in early phases, thus the aforementioned method may be useful as an adjuvant in the opportune detection of CuCa. In addition, the inventive method intends to reduce the percentage of false positive or negative obtained in the cytological detection test (Papanicolaou) and may increase the detection sensibility in the tests currently used for the diagnosis of CuCa.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2010005476A MX360181B (en) | 2010-05-19 | 2010-05-19 | Diagnosis method for the early detection of cervicouterine cancer by detecting the eag1 protein as a marker of cervical intraepithelial lesions. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2010005476A MX360181B (en) | 2010-05-19 | 2010-05-19 | Diagnosis method for the early detection of cervicouterine cancer by detecting the eag1 protein as a marker of cervical intraepithelial lesions. |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2010005476A MX2010005476A (en) | 2011-11-18 |
MX360181B true MX360181B (en) | 2018-10-16 |
Family
ID=45804149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010005476A MX360181B (en) | 2010-05-19 | 2010-05-19 | Diagnosis method for the early detection of cervicouterine cancer by detecting the eag1 protein as a marker of cervical intraepithelial lesions. |
Country Status (1)
Country | Link |
---|---|
MX (1) | MX360181B (en) |
-
2010
- 2010-05-19 MX MX2010005476A patent/MX360181B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
MX2010005476A (en) | 2011-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011015602A3 (en) | Lung cancer biomarkers | |
NZ601022A (en) | Diagnosis and treatment of cancer using anti-ereg antibody | |
MX2018004067A (en) | Quencher containing water soluble polymer-conjugated nanomaterial and use thereof. | |
NZ578283A (en) | Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring | |
NZ598194A (en) | Anti-cmet antibody and its use for the detection and the diagnosis of cancer | |
BR112013003391A2 (en) | pancreatic cancer biomarkers and their uses | |
EP4335932A3 (en) | Methods of monitoring conditions by sequence analysis | |
JP2014144959A5 (en) | ||
WO2014074835A3 (en) | Antibody compositions and immunoassay methods to detect isoforms of anti-mullerian hormone | |
WO2012017466A8 (en) | Use of hmgb1 as a biological marker of bowel inflammatory conditions, non-invasive method for its detection in fecal samples and kit thereof | |
WO2010136163A8 (en) | Secernin-1 as a marker for cancer | |
ATE554389T1 (en) | APEX AS A MARKER FOR LUNG CANCER | |
WO2015157704A3 (en) | Methods and compositions for detecting misfolded proteins | |
EP4067507A3 (en) | Pna probes, kits and methods for detecting genotypes of human papillomavirus | |
EP3159695A3 (en) | Methods for diagnosing pancreatic cancer | |
PE20141565A1 (en) | METHODS TO DETECT HUMAN PAPILLOMAVIRUS AND PROVIDE PROGNOSIS FOR SCAMOUS CELL CARCINOMA OF THE HEAD AND NECK | |
WO2010099137A3 (en) | In situ methods for monitoring the emt status of tumor cells in vivo | |
MX359376B (en) | Method and kit for determination of free copper in serum. | |
BR112014031957A2 (en) | bag3 as biochemical serum and tissue marker | |
WO2015077382A3 (en) | Combined cytology and molecular testing for early detection of esophageal adenocarcinoma | |
HK1136873A1 (en) | Use of nnmt as a marker for lung cancer | |
WO2011109112A3 (en) | Method of detecting tau protein and tau fragments in serum | |
BR112016002709A2 (en) | keratins as biomarkers for cervical cancer and survival | |
WO2012071405A3 (en) | Kits and assays for amplification of expressed salmonella genes from blood | |
AU2013231230A8 (en) | Method for selecting or identifying a subject for V1B antagonist therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |